Planning · template · CSVtoCSA editorial

Functional Risk Assessment Template

Version 2.0 · Updated 2026-09-21 · Planning

Link each important GxP function to a failure scenario, process effect, potential consequence, controls, and required evidence.

Adapt this template to your intended use, applicable requirements, and approved procedures.

When to use it

After intended use and requirements are sufficiently understood and before finalizing test depth.

Information needed before starting

  • Defined intended use and important requirements
  • Credible failure scenarios and consequences
  • Existing controls and available evidence

Field instructions

  • GxP function or requirement: Identify the function or requirement and its controlled reference. Explain the regulated process or record that depends on it.
  • Failure scenario: Describe a credible incorrect, missing or delayed result and trace it to the affected process, record or decision. Distinguish severity from how often it could occur.
  • Process effect: Describe a credible incorrect, missing or delayed result and trace it to the affected process, record or decision. Distinguish severity from how often it could occur.
  • Potential impact: Describe a credible incorrect, missing or delayed result and trace it to the affected process, record or decision. Distinguish severity from how often it could occur.
  • Existing controls: Describe the preventive or detective control, its owner and evidence that it works in the assessed configuration.
  • Detectability: Explain the remaining uncertainty and consequences after controls. State how an error would be detected before it affects the regulated decision.
  • Risk rationale: Explain the remaining uncertainty and consequences after controls. State how an error would be detected before it affects the regulated decision.
  • Mitigation or evidence needed: List the unanswered questions or missing evidence, the action owner and due date. Explain what cannot be concluded until they are resolved.
  • Residual risk: Explain the remaining uncertainty and consequences after controls. State how an error would be detected before it affects the regulated decision.
  • Owner: Identify the system/service or process, version and accountable roles. Specify the scope and supporting record rather than relying on a product name alone.

Assess functions separately rather than assigning one risk to the whole system.

Describe observable failure and process effect.

Credit only controls that address the failure and can be shown to work.

Use the remaining risk and uncertainty to select evidence.

Completed fictional example

Fictional teaching example; this is not an executed or approved validation record.

FieldCompleted example
GxP function or requirementCAPA closure gate; URS-014
Failure scenarioRecord closes before required effectiveness approval
Process effectOpen corrective action is represented as complete
Potential impactIneffective action may remain undetected
Existing controlsServer-side transition rule and role authorization
DetectabilityDaily exception report detects closure after the event
Risk rationaleHigh consequence; preventive gate is required
Mitigation or evidence neededScripted authorized and unauthorized transitions plus exploratory interruption and API paths
Residual riskUnexpected alternate integration path
OwnerQuality Systems Owner

Blank template

System / record ID: ____________________

Prepared by / date: ____________________

Required review / approval under local procedure: ____________________

FieldYour entry
GxP function or requirement____________________
Failure scenario____________________
Process effect____________________
Potential impact____________________
Existing controls____________________
Detectability____________________
Risk rationale____________________
Mitigation or evidence needed____________________
Residual risk____________________
Owner____________________
Relevant regulations and guidance

These sources apply within their stated scope. The suggested worksheet fields, test designs and fictional decisions are practitioner recommendations, unless a source requirement is expressly identified. Completing a template does not establish compliance.

Computer Software Assurance for Production and Quality Management System Software ↗

Regulatory guidance / GMP guideline · United States · February 2026

Scope: Medical-device manufacturers assuring software used in production or their quality management system.

Relevance: For medical-device production or QMS software, supports selecting assurance activities from intended use, risk and available evidence. It is nonbinding guidance and does not determine other sectors’ obligations.

Status: Final / published · Checked 2026-09-21

Publication identity, scope and status checked against the linked official source. This is not an independent audit of every retained guide statement.

Read source details and applicability →

EudraLex Volume 4, Annex 11 — Computerised Systems ↗

Regulatory guidance / GMP guideline · European Union · January 2011 revision

Scope: Computerised systems supporting activities in the applicable EU pharmaceutical GMP context.

Relevance: For computerised systems used in EU GMP activities, informs lifecycle, supplier and record controls. Confirm applicability to the actual activity; the example does not establish it.

Status: Final / published · Checked 2026-09-21

The Commission index confirms the January 2011 operative revision. The linked PDF could not be retrieved in this check; retained detailed section mappings need review against an authorized copy.

Read source details and applicability →
Was this useful? Leave feedback

Was this resource useful?

Was this template clear and useful? Tell us which instruction or field could be improved.

Loading contribution options…

Questions and moderated discussion

Questions and discussion

Ask a question or share a perspective. Contributions are reviewed before publication.

Loading contribution options…

Suggest a correction

Sent privately to the editorial moderation queue. Your account email and correction are not published as a comment. Do not include confidential or personal information.

Resource: Functional Risk Assessment Template

Loading sign-in status…

Correction details